Access the Platform
In light of the high number of COVID-19 cases and concerns about the new SARS-CoV-2 variant, ESMO has made the decision to hold the ESMO Sarcoma & GIST Symposium 2022 as a virtual event only, with no in-person participation in Milan.
The safety of our faculty and delegates remains our top priority at this difficult time.
We are confident that our virtual format will effectively disseminate the latest advances in sarcoma and GIST and give experts from all around the world the chance to identify promising new research avenues.
ESMO’s Sarcoma & GIST Symposium is a highly specialised meeting bringing together the most brilliant medical minds working on these tumour types. The Symposium is known as the place of choice for international networking and collaboration, featuring discussions with the key opinion leaders in these rare sub-entities. The Symposium brings translational researchers and clinicians together and builds on an integrated approach for improved patient outcomes.
Who should attend this Symposium?
- Medical oncologists
- Surgical oncologists
- Judith Bovée, Leiden, Netherlands
- Robin L. Jones, London, UK
- Paolo G. Casali, Milan, Italy
- Jean-Yves Blay, Lyon, France
- A. Paolo Dei Tos, Padua, Italy